KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION Patent applications |
Patent application number | Title | Published |
20160141516 | LIGHT EMITTING MATERIAL, DELAYED FLUORESCENT EMITTER, ORGANIC LIGHT EMITTING DEVICE, AND COMPOUND - A compound represented by the following general formula is useful as a light emitting material. X represents an oxygen atom or a sulfur atom. R | 05-19-2016 |
20160137505 | METHOD FOR SEPARATING METALLIC SINGLE-WALLED CARBON NANOTUBE FROM SEMICONDUCTIVE SINGLE-WALLED CARBON NANOTUBE - Provided is a novel method for efficiently separating a metallic SWNT and a semiconducting SWNT from single-walled carbon nanotubes (SWNTs). The present invention is a method for separating a metallic SWNT and a semiconducting SWNT from SWNTs, said method comprising: dispersing the SWNTs in a solution containing a low-molecular-weight compound having an alkyl chain moiety for exhibiting solubility in a solvent and an aromatic-ring-containing moiety for interacting with the SWNTs; and separating the dispersion into a solution fraction and a solid fraction. | 05-19-2016 |
20160111626 | FLEXIBLE CONDUCTIVE MATERIAL AND TRANSDUCER - A flexible conductive material of the present invention is formed by dispersing a conductive agent containing carbon nanotubes in a matrix that contains a polymer formed by amide bond formation or imide bond formation of a polycyclic aromatic component and an oligomer component and that has a glass transition point of 20° C. or less. The flexible conductive material of the present invention has good dispersibility of a conductive agent containing carbon nanotubes and has an excellent following performance to an expanding and shrinking substrate. A transducer of the present invention includes a dielectric layer made of a polymer, a plurality of electrodes with the dielectric layer interposed therebetween, and wirings connected to the respective electrodes, and at least either the electrodes or the wirings include the flexible conductive material of the present invention. The transducer of the present invention has a performance that is unlikely to deteriorate due to the electrodes or the wirings and has excellent durability. | 04-21-2016 |
20160058856 | ANTI-TUMOR DNA VACCINE - The present invention provides a pharmaceutical composition for treating a tumor, which is a micelle encapsulating at least one tumor-associated antigen gene. The present invention also provides a method for treating a tumor, comprising administering a micelle encapsulating at least one tumor-associated antigen gene to a patient in need of such treatment. | 03-03-2016 |
20160035603 | LASER ANNEALING APPARATUS - Provided is a laser annealing apparatus that may include: a laser light source section configured to output pulsed laser light to be applied to a thin film formed on a workpiece; a pulse width varying section configured to vary a pulse width of the pulsed laser light; a melt state measuring section configured to detect that the thin film irradiated with the pulsed laser light is in a melt state; and a controlling section configured to determine, based on a result of detection by the melt state measuring section, a duration of time during which the thin film is in the melt state, and to control the pulse width varying section to allow the duration of time to be of a predetermined length. | 02-04-2016 |
20160023197 | MONONUCLEAR RUTHENIUM COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME - Provided is a mononuclear ruthenium complex that comprises a ruthenium-silicon bond that is represented by formula (1) and that exhibits excellent catalyst activity in each of a hydrosilylation reaction, a hydrogenation reaction, and reduction of a carbonyl compound. | 01-28-2016 |
20160023196 | MONONUCLEAR IRON COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME - Provided is a mononuclear iron complex that comprises an iron-silicon bond that is represented by formula (1) and that exhibits excellent catalyst activity in each of a hydrosilylation reaction, a hydrogenation reaction, and reduction of a carbonyl compound. | 01-28-2016 |
20160015590 | HAND EXOSKELETON DEVICE - In a hand exoskeleton device, according to a three-layered sliding spring mechanism, the motion of the device is changed by a single drive mechanism to transmit power to the metacarpophalangeal, proximal and distal interphalangeal joints of a human finger, thereby enabling support of the daily activity motions of the finger. According to the hand exoskeleton device, when compared with a conventional device, there can be realized a device which is small in size and weight and is capable of supporting the gripping motions of the human finger. The hand exoskeleton device is characterized in that the three joints of the finger can be bent and extended by the single drive mechanism and it can transmit large drive power. Further, the device body is flexible, thereby enabling safe movement. | 01-21-2016 |
20160000750 | COMBINATION OF EGCG OR METHYLATED EGCG AND A PDE INHIBITOR - Disclosed is a medicament characterized by the combination of: epigallocatechin gallate, methylated epigallocatechin gallate, or a pharmacologically permitted salt thereof; and a phosphodiesterase inhibitor. | 01-07-2016 |
20150371850 | METHOD OF FORMING SEMICONDUCTOR THIN FILM - Provided is a method of forming a semiconductor thin film. The method may include forming, on a substrate, a thin film that contains one of Ge, Si, and a SiGe mixture, and Sn in a content of 0.1 atomic % or more to 20 atomic % or less, and applying pulsed laser light to the thin film. | 12-24-2015 |
20150343401 | METHOD AND DEVICE FOR PRODUCING COMPOSITION HAVING DISPERSE PHASE DISPERSED IN CONTINUOUS PHASE - An object of the present invention is to provide a method for producing, with high productivity, a composition having a disperse phase dispersed with a small particle size in a continuous phase. | 12-03-2015 |
20150310958 | STRUCTURE CONTAINING METAL MICROPARTICLES - The present invention addresses the problem of providing a structure which comprises metal plate microparticles and a lipophilic clay-based intercalation compound and which exhibits excellent stability. The problem is solved by a structure as described above wherein: the metal plate microparticles are platy microparticles alone or a mixture thereof with polyhedral microparticles (including spherical microparticles); the platy microparticles have a thickness of 1 to 50 nm, a length of principal plate of 10 to 5000 nm and an aspect ratio thereof of 3 or more; and the weight ratio of the lipophilic clay-based intercalation compound to the metal plate microparticles is 0.01 to 50. | 10-29-2015 |
20150295243 | CATHODE ACTIVE MATERIAL, LITHIUM BATTERY AND METHOD OF PRODUCING CATHODE ACTIVE MATERIAL - The problem of the present invention is to provide a cathode active material which performs favorable discharge capacity. The present invention solves the problem by providing a cathode active material comprising a crystal phase of an inverse-spinel structure represented by LiM | 10-15-2015 |
20150295237 | CATHODE ACTIVE MATERIAL FOR LITHIUM BATTERIES, AND LITHIUM BATTERY COMPRISING THE CATHODE ACTIVE MATERIAL FOR LITHIUM BATTERIES - The present invention is to provide a cathode active material configured to increase, when used in a lithium battery, the discharge capacity of the lithium battery higher than conventional lithium batteries, and a lithium battery including the cathode active material. Presented is a cathode active material for lithium batteries, wherein the cathode active material is represented by the following composition formula (1) and has a rock salt type crystal structure including formula (1): Li | 10-15-2015 |
20150284762 | METHOD FOR PRODUCING PROTEIN-NUCLEIC ACID CONJUGATE, AND METHOD FOR DETECTING TARGET SUBSTANCE - Provided is a method for producing a nucleic acid probe that can detect a target substance with good sensitivity. A method for producing a nucleic acid probe, comprising: a 3′-terminal addition step of adding at least one nucleoside triphosphate derivative having a glutamine (Gln) residue or a lysine (Lys) residue to the 3′-terminal of a nucleic acid using a 3′-terminal addition enzyme which adds a nucleotide to the 3′-terminal of a nucleic acid, and a labeling compound binding step of either binding a labeling compound having a lysine (Lys) residue and containing a labeling moiety to the glutamine (Gln) residue using a transglutaminase (TGase), or binding a labeling compound having a glutamine (Gln) residue and containing a labeling moiety to the lysine (Lys) residue using a transglutaminase (TGase). | 10-08-2015 |
20150284468 | METHOD FOR TREATMENT OF BLOOD TUMOR USING ANTI-TIM-3 ANTIBODY - Disclosed is a therapeutic method including administering a TIM-3 antibody or its TIM-3 binding fragment to a subject who is suspected to be suffering from blood tumor and in whom TIM-3 has been expressed in a Lin(−)CD34(+)CD38(−) cell fraction of bone marrow or peripheral blood or a subject who has been received any treatment for blood tumor. Conceived diseases include those diseases which can be treated through the binding or targeting of the TIM-3 antibody or its TIM-3 binding fragment to blood tumor cells (AML cells, CML cells, MDS cells, ALL cells, CLL cells, multiple myeloma cells, etc.), helper T cell (e.g., Th1 cells, Th17 cells), and antigen-presenting cells (e.g., dendritic cells, monocytes, macrophages, and cells resembling to the aforementioned cells (hepatic stellate cells, osteoclasts, microglial cells, intraepidermal macrophages, dust cells (alveolar macrophages), etc)). | 10-08-2015 |
20150280142 | ORGANIC MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT - An organic material represented by the following General Formula (1): | 10-01-2015 |
20150263366 | PAPER-STRUCTURED CATALYST, PAPER-STRUCTURED CATALYST ARRAY BODY, AND SOLID OXIDE FUEL CELL PROVIDED WITH PAPER-STRUCTURED CATALYST OR PAPER-STRUCTURED CATALYST ARRAY BODY - This invention provides a paper-structured catalyst which exhibits high catalytic activity for hydrocarbon reforming to increase the efficiency of hydrocarbon reforming, and is tolerant to thermal shock to cause destruction of the catalyst structure and clogging and destruction of catalyst voids, and an internal reforming solid oxide fuel cell with the paper-structured catalyst. The paper-structured catalyst according to the present invention is composed of a paper-structured porous support prepared by forming inorganic fibers in a paper-like shape and catalyst metal which is loaded dispersedly on a surface of the paper-structured porous support and has reforming activity against hydrocarbons. The inorganic fibers constituting the paper-structured porous support contain at least partially ion conductive oxide fibers. The reforming activity of the paper structured catalyst against hydrocarbons is high, and the catalyst is tolerant to thermal stress fracture and can easily be formed into a desired size and shape, and the degree of freedom for making catalyst array is high. Since an internal reforming solid oxide fuel cell with the paper-structured catalyst according to the present invention as a hydrocarbon reforming catalyst can suppress thermal stress fracture, and degradation due to carbon deposition, resulting in more stable power generation. | 09-17-2015 |
20150246848 | LASER PROCESSING APPARATUS AND LASER PROCESSING METHOD - Included are a laser light source ( | 09-03-2015 |
20150241353 | METHOD AND SYSTEM FOR OPTICAL ANALYSIS - A method for optical analysis, which enables a point of care testing to optically analyze a specimen with a disposal microchip. The method uses a portable terminal device having a processing unit, a light receiving unit, and a display unit for displaying processing results of the processing unit. The microchip has a light introducing portion and a light emitting portion, but does not have a light source. The specimen is held in an optical path extending from the light introducing portion to the light emitting portion. The specimen is irradiated with light for analysis of the specimen. The method includes preparing another optical path for guiding light emitted from the light emitting portion of the microchip to the light receiving portion, and introducing the light into the light introducing portion. | 08-27-2015 |
20150231164 | SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME - Disclosed are a sirtuin gene potentiator, and a pharmaceutical product, a cosmetic product, and a food product using the same. The sirtuin gene potentiator of the present invention contains a given polyphenol and/or terpenoid as an active component. The polyphenol and/or the terpenoid can be contained in the form of a plant such as pomegranate or a plant extract thereof. The sirtuin gene potentiator of the present invention is available from a familiar material to avoid concerns such as side effects on the human body in advance. Such a sirtuin gene potentiator is useful as a novel material in the fields of pharmaceutical products, cosmetic products, and food products. | 08-20-2015 |
20150225236 | METAL COMPLEX AND METHOD FOR PRODUCING HYDROGEN PEROXIDE - An object of the present invention is to provide a novel method for producing hydrogen peroxide by direct synthesis that is capable of taking the place of the conventional anthraquinone process, and to provide a catalyst used in the production method. | 08-13-2015 |
20150204697 | CONDUCTIVE MATERIAL, METHOD FOR PRODUCING THE CONDUCTIVE MATERIAL, AND TRANSDUCER INCLUDING THE CONDUCTIVE MATERIAL - A conductive material includes metal nanowires and an extensible copolymer having an N—C═O structure and combined with the metal nanowires. The conductive material has excellent elongation properties and has an electrical resistance that is unlikely to increase even when the conductive material is extended. A method for producing a conductive material includes: a copolymer production step of polymerizing a plurality of monomers including a growth direction control monomer that has an N—C═O structure and controls a growth direction of metal nanowires to produce an extensible copolymer; a reaction step of reacting a metal compound in a solvent containing the copolymer to grow metal nanowires in a longitudinal direction; and an extraction step of extracting a product from the solution after the reaction. | 07-23-2015 |
20150185512 | LIQUID-CRYSTAL DISPLAY ELEMENT AND SUBSTRATE USED IN SAME - A substrate used for a liquid crystal display element having two or more substrates arranged oppositely to each other and a liquid crystal material exhibiting a blue phase between the substrates, where a polar component of surface free energy on a substrate surface in contact with the liquid crystal material is less than 5 mJm | 07-02-2015 |
20150177082 | FORCE SENSOR AND ROBOT HAVING FORCE SENSOR - A force sensor according to embodiments includes a light-emitting unit, a pair of first light detectors, a reflector, and a first frame. The light-emitting unit emits diffuse light. The first light detectors are arranged in a first direction with the light-emitting unit interposed therebetween. The reflector is arranged to face the light-emitting unit on an optical axis of the light-emitting unit and reflects the diffuse light emitted from the light-emitting unit toward the first light detectors. The first frame is deformed in the first direction so that a reflection range of the diffuse light reflected by the reflector is displaced in the first direction. | 06-25-2015 |
20150153279 | LIGHT MEASURING APPARATUS, LIGHT MEASURING METHOD, FILTER MEMBER, AND LIGHT-INDUCED FLUORESCENT MEASURING DEVICE - A laser light source for emitting excitation light, a sample case, a photomultiplier tube, a fluorescence collecting optical system and so forth are embedded in a resin material that is transparent to the excitation light and the light including fluorescence emitted from a sample. The resin material is provided in at least part of a light path that guides the fluorescence in the fluorescence collecting optical system, and this resin forms a housing that holds the laser light source, the fluorescence collecting optical system, the photomultiplier and so forth. A pigment having wavelength characteristics for absorbing the excitation light, Raman light generated from the resin, and so forth is contained substantially in a uniform manner in a resin region that surrounds the light path through which the excitation light and the light including the fluorescence pass. | 06-04-2015 |
20150151239 | GAS SEPARATION DEVICE AND GAS SEPARATION METHOD - A gas separation device having a simple structure and reducing the cost incurred in gas separation. The gas separation device ( | 06-04-2015 |
20150151238 | GAS SEPARATION DEVICE - A simple and inexpensive gas separation device is provided. The gas separation device ( | 06-04-2015 |
20150141642 | LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE - A light-emitting material containing a compound represented by the following general formula in a light-emitting layer has high light emission efficiency. In the following general formula, R | 05-21-2015 |
20150141510 | CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN - The present invention provides the following: a cardiovascular disease primary prevention agent, which comprises as the active ingredient at least one selected from the group consisting of EPA, salts thereof, and esters thereof and is for lowering the risk of cardiovascular disease by administration to subjects having a blood (serum or plasma) hs-CRP level of 1.0 mg/L or higher in spite of no history of cardiovascular disease; a combination marker comprising the blood hs-CRP value and serum EPA/AA ratio for evaluating the primary risk of cardiovascular disease in subjects having no history of cardiovascular disease; and a method for extracting subjects with high risk of cardiovascular disease and/or a method for preventing cardiovascular disease. | 05-21-2015 |
20150139892 | METHOD FOR PRODUCING HYDROGEN PEROXIDE - An object of the present invention is to provide a method by which hydrogen peroxide can be produced at a satisfactory level from an industrial and economical viewpoint without causing the load of purification to be large and without needing too large facilities for production. The present invention is directed to a method for producing hydrogen peroxide, which comprises reacting hydrogen and oxygen in a reaction medium in the presence of a noble metal catalyst and a radical scavenger. | 05-21-2015 |
20150122303 | THERMOELECTRIC CONVERSION MATERIAL USING SUBSTRATE HAVING NANOSTRUCTURE, AND METHOD FOR PRODUCING SAME - The present invention provides a thermoelectric conversion material having a low thermal conductivity and having an improved figure of merit, and a method for producing it. The thermoelectric conversion material has, as formed on a substrate having a nano-level microporous nanostructure, a thermoelectric semiconductor layer prepared by forming a thermoelectric semiconductor material into a film, wherein the substrate is a block copolymer substrate formed of a block copolymer that comprises a polymethyl methacrylate unit and a polyhedral oligomeric silsesquioxane-containing polymethacrylate unit, and the thermoelectric semiconductor material is a p-type bismuth telluride or an n-type bismuth telluride. The production method comprises a substrate formation step of forming the nanostructure-having block copolymer substrate, and a film formation step of forming a p-type bismuth telluride or an n-type bismuth telluride into a film to thereby provide a thermoelectric semiconductor layer. | 05-07-2015 |
20150111085 | Separator for Electrochemical Element and Fabrication Method for Same - The present invention provides a novel separator which has a high heat resistance property and excels in flexibility, and a fabrication method of the separator. The present invention relates to a separator for an electrochemical element consisting of a porous base material containing inorganic fibers and an organic substance, wherein a part or all of the inorganic fibers are covered with the organic substance, and the inorganic fibers are bound through the organic substance. | 04-23-2015 |
20150105559 | PRODUCTION METHOD FOR COMPOUND COMPRISING AMINO GROUP AND/OR HYDROXYL GROUP - Disclosed is a method for producing a compound having an amino group and/or a hydroxyl group from a substrate compound having an atomic group containing CO or CS by eliminating such atomic group. The substrate compound, having an atomic group containing CO or CS (for example, an amide, a carbamate, or the like), is allowed to react with a compound expressed by formula (I) below, at a temperature of 120° C. or lower, preferably in the presence of an ammonium salt, to eliminate such atomic group containing CO or CS. In formula (I) A may not be present, and in a case where A is present, A represents an alkyl group having 1 to 6 carbon atoms. H | 04-16-2015 |
20150105442 | Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule - Provided is a novel molecule that inhibits the expression of the periostin gene. Also provided are methods of inhibiting the expression of the periostin gene or treating an eye disease using the same. | 04-16-2015 |
20150085282 | LIGHT MEASURING APPARATUS, LIGHT MEASURING METHOD, FILTER MEMBER, AND METHOD OF MAKING FILTER MEMBER - A light measuring arrangement maintains the initial filtering function of an optical filter having a dye dispersed therein. The light measuring arrangement includes a measuring unit configured to measure an intensity of light emitted from a measurement target at a predetermined wavelength. The light measuring arrangement also includes the optical filter unit having the dye. The light measuring arrangement also includes a dye diffusion restricting unit configured to restrict diffusion of the dye from the optical filter unit. The optical filter unit constitutes part of an optical path for the light traveling from the measurement target to the light measuring unit. | 03-26-2015 |
20150025591 | STIMULATION DEVICE AND METHOD FOR TREATING CARDIOVASCULAR DISEASE - An electrical stimulation device and method are provided for treating cardiovascular disease in a human or an animal, the device including at least one electrode configured for placement on a nerve site inside the human or the animal, the at least one electrode having a spherical shape, and an electrical stimulation application unit coupled to the at least one electrode and configured to apply electrical stimulation to a vagus nerve in a neck region of the human or the animal by the at least one electrode. | 01-22-2015 |
20150025298 | STIMULATION DEVICE AND METHOD FOR TREATING CARDIOVASCULAR DISEASE - A stimulation device and method for treating cardiovascular disease in a human or an animal is provided, the method including placing a magnetic pulse application unit including a coil on a skin surface of a region of the human or the animal, and generating magnetic pulses around the coil, wherein the magnetic pulses induce currents in tissues in the region to stimulate a vagus nerve. The region may be a neck region or a chest region. | 01-22-2015 |
20140378441 | THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE - Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient. | 12-25-2014 |
20140363875 | NOVEL DNA POLYMERASE - Provided are various novel DNA polymerases. | 12-11-2014 |
20140335521 | Method for Designing RNA Binding Protein Utilizing PPR Motif, and Use Thereof - A method for designing a protein capable of binding in an RNA base selective manner or RNA base sequence specific manner is provided. The protein of the present invention is a protein containing one or more of PPR motifs (preferably 2 to 14 PPR motifs) each consisting of a polypeptide of 30- to 38-amino acid length represented by the formula 1 (wherein Helix A is a moiety of 12-amino acid length capable of forming an α-helix structure, and is represented by the formula 2, wherein, in the formula 2, A | 11-13-2014 |
20140327434 | MAGNETIC FIELD SENSOR - Provided is a magnetic field sensor with which it is possible to simultaneously operate a DC flux gate magnetometer and a search coil magnetometer, a sensor is miniaturized by the DC flux gate magnetometer and the search coil magnetometer being positioned close to one another, and it is possible to measure a magnetic field from a DC magnetic field to an AC magnetic field of a high-frequency region of either the same point or points in close proximity. | 11-06-2014 |
20140322793 | NOVEL DNA POLYMERASES - Provided are various novel DNA polymerases. Provided is a DNA polymerase comprising an amino acid sequence modified from the amino acid sequence of SEQ ID NO: 8 by inserting nine amino acids “-A | 10-30-2014 |
20140296074 | Superconducting Magnet and Nuclear Magnetic Resonance Device - There is provided a superconducting magnet in which magnetization caused by a shielding current of a superconducting winding is eliminated whereby the current to be supplied to the superconducting winding is uniformized, and thus uniformity of the central magnetic field is secured. The superconducting magnet has a superconducting winding composed of a superconductor, and an outer AC winding composed of a superconductor or non-superconductor wound coaxially with the superconducting winding, at an outer side the superconducting winding; and an AC current is supplied to the outer AC winding thereby applying an AC magnetic field in a direction perpendicular to a direction of magnetization caused in the superconducting winding by the shielding current, and thus the magnetization is eliminated. Also, the superconducting magnet has an inner AC winding composed of a superconductor or non-superconductor wound coaxially with the superconducting winding, at an inner side of the superconducting winding layer. | 10-02-2014 |
20140294707 | SYSTEM, DEVICE AND METHOD FOR GENERATING ION CONCENTRATION GRADIENT, AND TEMPERATURE-RESPONSIVE ELECTROLYTE MATERIAL - A system for producing an ion concentration gradient and a temperature-responsive electrolyte material which are utilizable, for example, for efficiently converting heat energy that has been discarded into reusable energy or for efficiently recovering an acid gas, such as carbon dioxide is provided. A temperature-responsive electrolyte is used to produce an ion concentration gradient by means of a temperature gradient. The temperature-responsive electrolyte is used in the state of an aqueous solution and also in the state of a solid phase. | 10-02-2014 |
20140294032 | SOLID-STATE DYE LASER MEDIUM AND PROCESS FOR PRODUCTION THEREOF - The challenge of providing a long-life solid-state dye laser medium is tackled. This challenge is solved by a solid-state dye laser medium comprising a polydimethylsiloxane, and a dye dissolved in the polydimethylsiloxane. The dye is preferably a pyrromethene dye. | 10-02-2014 |
20140291573 | METHOD FOR PRODUCING IRON OXYFLUORIDE POSITIVE ELECTRODE ACTIVE SUBSTANCE AND IRON OXYFLOURIDE POSITIVE ELECTRODE ACTIVE SUBSTANCE - Provided is a technology for producing a positive electrode active substance mainly composed of FeOF having a sufficient charge-discharge capacity, in the short-time and easy manner. Also provided is a positive electrode active substance mainly composed of FeOF. The method for producing the positive electrode active substance mainly composed of FeOF comprises the steps of admixing iron oxide Fe | 10-02-2014 |
20140248494 | TRANSPARENT CONDUCTOR AND METHOD FOR PRODUCING SAME - A method for producing a transparent conductor includes the step of forming an undercoat layer containing a hole doping compound at a proportion of 0.2 to 20% by weight on the transparent substrate before forming the electrically conductive layer, or the step of forming an overcoat layer containing a hole doping compound at a proportion of 0.2 to 20% by weight after forming the electrically conductive layer. Also provided is a transparent conductor having an undercoat layer containing a hole doping compound at a proportion of 0.2 to 20% by weight and an electrically conductive layer containing carbon nanotubes in this order, or an electrically conductive layer containing carbon nanotubes and an overcoat layer containing a hole doping compound at a proportion of 0.2 to 20% by weight in this order, on at least one surface of the transparent substrate. | 09-04-2014 |
20140234187 | VALUABLE METAL EXTRACTION AGENT AND VALUABLE METAL EXTRACTION METHOD USING SAID EXTRACTION AGENT - The objective of the present invention is to selectively extract light rare earth metals, and by extension, europium, from an acidic solution containing a plurality of types of rare earth metal. This valuable metal extraction agent is represented by the general formula. In the formula: R | 08-21-2014 |
20140154763 | METHOD FOR PRODUCING ETHANOL USING BASIDIOMYCETE - An object of the present invention is to provide a means for conveniently producing ethanol with high efficiency from a carbon source derived from a plant biomass resource or the like. The present invention relates to a method for producing ethanol, comprising a step of generating ethanol by culturing basidiomycetes belonging to the genus | 06-05-2014 |
20140138670 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND COMPOUND USED THEREIN - An organic electroluminescence element in which a compound represented by the general formula below is used in a light-emitting layer exhibits a high emission efficiency and is inexpensive to provide. At least one of R | 05-22-2014 |
20140138669 | DELAYED-FLUORESCENCE MATERIAL AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME - A delayed fluorescence material comprising a compound represented by the general formula below. At least one of R | 05-22-2014 |
20140135530 | NOVEL COMPOUND AND ORGANIC DEVICE EMPLOYING SAME - The compounds represented by the following general formula have excellent properties as a charge transport material. In the formula, R | 05-15-2014 |
20140134639 | METHOD FOR TREATMENT OF BLOOD TUMOR USING ANTI-TIM-3 ANTIBODY - Disclosed is a therapeutic method including administering a TIM-3 antibody or its TIM-3 binding fragment to a subject who is suspected to be suffering from blood tumor and in whom TIM-3 has been expressed in a Lin(−)CD34(+)CD38(−) cell fraction of bone marrow or peripheral blood or a subject who has been received any treatment for blood tumor. Conceived diseases include those diseases which can be treated through the binding or targeting of the TIM-3 antibody or its TIM-3 binding fragment to blood tumor cells (AML cells, CML cells, MDS cells, ALL cells, CLL cells, multiple myeloma cells, etc.), helper T cell (e.g., Th1 cells, Th17 cells), and antigen-presenting cells (e.g., dendritic cells, monocytes, macrophages, and cells resembling to the aforementioned cells (hepatic stellate cells, osteoclasts, microglial cells, intraepidermal macrophages, dust cells (alveolar macrophages), etc)). | 05-15-2014 |
20140133507 | Semiconductor Laser - A semiconductor laser is provided with one or more rear ports and one front port and with a multi-mode interference optical waveguide that has an active layer (light emitting layer) in all regions in plan view. The front port corresponds to an imaging point at which fundamental mode light forms an image in the active layer (light emitting layer) perpendicular to the waveguide direction of the multi-mode interference optical waveguide, and in plan view the front port is disposed along a central line, off center with respect to a central line, along the waveguide direction of the multi-mode interference optical waveguide. | 05-15-2014 |
20140120072 | METHOD FOR AMPLIFYING NK CELLS - A technique is needed which can amplify NK cells in vitro and prepare optimum number of NK cells for the adoptive immunotherapy. | 05-01-2014 |
20140086996 | WATER-SOLUBLE DRUG CARRIER AND PROCESS FOR PRODUCING THE SAME - An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver water-soluble drugs such as genes and proteins in a wide range of applications, including delivery of water-soluble drugs that do not have high anionic properties, and also can be used as a non-viral gene vector. The invention also provides a process for production of such drug delivery carriers. The drug delivery carrier of the present invention includes a water-soluble drug double-coated with two types of inner and outer surfactants 1 and 2. | 03-27-2014 |
20140072503 | FINE CRYSTAL PARTICLE PRODUCTION METHOD AND DEVICE HAVING EXCELLENT MIXING EFFICIENCY - An object of the present invention is to provide a fine crystal particle production method and device that are excellent in mixing efficiency. | 03-13-2014 |
20140058099 | NOVEL COMPOUND, CHARGE TRANSPORT MATERIAL, AND ORGANIC DEVICE - The compounds represented fey the following general formula is is thermally stable and has excellent characteristics as a charge transport material [Ar | 02-27-2014 |
20140051774 | METHOD AND DEVICE FOR PRODUCING COMPOSITION HAVING DISPERSED PHASE FINELY DISPERSED IN CONTINUOUS PHASE - An object of the present invention is to provide a method for producing a composition having a disperse phase finely dispersed in a continuous phase with low polydispersity, the method which is excellent in production efficiency | 02-20-2014 |
20140045955 | METHOD OF MANUFACTURING OLEFIN HAVING 2 TO 4 CARBON ATOMS BY FISCHER-TROPSCH REACTION - Provided are a method of manufacturing an olefin having 2 to 4 carbon atoms including: reacting a catalyst with synthesis gas through a Fischer-Tropsch reaction, thereby obtaining the olefin having 2 to 4 carbon atoms, in which the catalyst is a catalyst obtained by reducing the iron ion and the cobalt ion in a dispersion liquid or a solution containing the iron ion, the cobalt ion and a dispersant that interacts with the iron ion and the cobalt ion, and a method of manufacturing propylene, which uses the above manufacturing method. | 02-13-2014 |
20140044728 | ANTI-TIM-3 ANTIBODY - Disclosed are an anti-human TIM-3 antibody having high ADCC activity or antibody fragment thereof by screening a monoclonal antibody or antibody fragment thereof which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure and exhibits ADCC activity; a hybridoma which produces the antibody; a DNA encoding the antibody; a vector comprising the DNA; a transformant which is obtainable by introducing the vector; a method for producing the antibody or the antibody fragment thereof which comprises using the hybridoma or the transformant; and a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment thereof as an active ingredient. | 02-13-2014 |
20140034936 | COMPOUND HAVING SUBSTITUTED TRIPHENYLENE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE - An organic compound having an excellent electron injection and transport performance is provided as a material for a low-power-consumption organic electroluminescent device. A low-power-consumption organic electroluminescent device is also provided by using the compound. The compound is a compound of general formula (1) or (2) having a substituted bipyridyl and triphenylene ring structure. The organic electroluminescent device includes a pair of electrodes, and one or more organic layers sandwiched between the pair of electrodes, and uses the compound as constituent material of at least one of the organic layers. | 02-06-2014 |
20140034935 | COMPOUND HAVING SUBSTITUTED ORTHO-TERPHENYL STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE - A light-emitting-layer host material is provided as material for high-efficiency organic electroluminescent devices. The light-emitting-layer host material has a high excitation triplet level, and is capable of completely confining the triplet excitons of phosphorescent material. A high-efficiency and high-luminance organic electroluminescent device is provided by using the compound. The compound is a compound of general formula (1) having a bipyridyl group and an ortho-terphenyl structure. The organic electroluminescent device includes a pair of electrodes, and one or more organic layers sandwiched between the pair of electrodes, and uses the compound as constituent material of at least one of the organic layers. | 02-06-2014 |
20140030155 | COMPLEX SYSTEM FOR UTILIZING COAL IN MANUFACTURE OF CHAR AND RAW MATERIAL GAS AND ELECTRIC POWER GENERATION - Most of the abundant naturally occurring low rank coal, which has a high moisture content and a high oxygen content, is transported with poor efficiency; utilized for heating with degraded thermal efficiency because of the loss of heat due to sensible heat for heating moisture and latent heat for vaporizing moisture; and utilized in existing coal combustion facilities with difficulty due to a high volatile component content. A complex system of the present invention for utilizing coal for manufacture of char and raw material gas and electric power generation is adopted to include: a drying unit for drying low rank coal of a high moisture content; a reformer for reforming the low rank coal that has been dried in the drying unit; a fluidized bed combustor for employing, as a fuel, the reformed coal obtained in the reformer; a producer gas supply pipe for supplying a combustion exhaust gas from the fluidized bed combustor as a pyrolytic and gasifying agent to the reformer; and a catalyst reforming unit for reforming a volatile component and the producer gas obtained from the low rank coal reformed in the reformer. | 01-30-2014 |
20140022934 | TRANSMISSION PERIOD DETERMINATION METHOD, TRANSMISSION PERIOD DETERMINATION DEVICE AND PROGRAM - A transmission period determination method, etc. capable of setting IPT transmission period by using general-purpose wireless modules and existing drivers is provided. A wireless communication system is a wireless backhaul. A route is established from a core node to a slave node. The core node assigns a specified transmission period and transmits a plurality of training packets to the slave node. The slave node transmits, to a transmission period determination device, the number of training packets received first and last and the number of training packets received without overlap. An estimation unit estimates a training time, the time for the slave node to receive the training packets. A calculation unit calculates a training metric candidate. An updating unit compares the values of the current training metric and the training metric candidate to determine the IPT transmission period. | 01-23-2014 |
20130323670 | MOUTH OPENING INSTRUMENT AND METHOD - A mouth opening instrument includes an upper member suitable for attaching on an upper jaw side within the mouth of a patient and a lower member suitable for attaching on a lower jaw side. The instrument further includes a connecting section, a control section, and an input section. The connecting section connects end portions of the upper member and the lower member such that a resistance of opening or closing actions of the upper member and the lower member are controllable. The control section controls the resistance of opening or closing actions of the upper member and the lower member. The input section receives an operating state signal indicating an operating state of a dental treatment device. When the operating state signal indicating an operating state of a dental treatment device is inputted, the closing resistance of the upper member and the lower member is set to be greater than that at a time when the operating state signal is not inputted. | 12-05-2013 |
20130316298 | METHOD AND APPARATUS FOR SUPPORTING DENTAL IMPLANTATION SURGERY - In a method and apparatus for supporting dental implantation surgery, a three-dimensional CT image of jaws of an object is acquired. A reference site of the jaws and an implantation position of a gum in the jaws are set in the three-dimensional CT image. The implant is implanted at the implantation position. A three-dimensional optical image of an inside of an oral cavity of the object is then produced. The reference site is positionally set in the three-dimensional optical image through recognition of a shape of the reference site in the three-dimensional optical image. A surgical tool is positionally controlled to the implantation position in the oral cavity, based on i) a relationship between the position of the reference site and the implantation position of the gum in the three-dimensional CT image and ii) the position of the reference site in the three-dimensional optical image. | 11-28-2013 |
20130309772 | METHOD FOR TRANSFORMATION OF STRAMENOPILE - To provide a transformation method for producing a stramenopile organism having an improved unsaturated fatty acid production capability by disrupting a gene of the stramenopile organism or inhibiting the expression of the gene in a genetically engineering manner. [Solution] A method for transforming a stramenopile organism, which comprises disrupting a gene of the stramenopile organism or inhibiting the expression of the gene in a genetically engineering manner, and which is characterized in that the stramenopile organism is selected from | 11-21-2013 |
20130277665 | ORGANIC EL ELEMENT AND METHOD FOR MANUFACTURING SAME - An organic EL element comprises: a substrate; a first electrode formed at one surface side of the substrate; a second electrode opposing the first electrode; and an organic EL layer located between the first and second electrodes. In the organic EL element, the second electrode is a transparent electrode, and the first electrode is a reflecting electrode. The organic EL element is a top-emission type. The first electrode comprises a plurality of nanometer-size (nanometer-order) columnar structures formed on the above-mentioned one surface of the substrate, and each of the plurality of columnar structures has a metallic surface as the outermost surface. | 10-24-2013 |
20130272345 | PACKET COMMUNICATION SYSTEM, EMISSION CONTROL APPARATUS, ANTENNA CONTROL METHOD AND COMPUTER PROGRAM - A packet communication system etc., is proposed, which can automatically adjusting the antenna directionality without modifying a wireless interface of a wireless packet forwarding device even if it involves fluctuation in the packet transmission timing due to CSMA/CA etc. An interference evasion unit involves fluctuation in packet transmission timing due to CSMA/CA. A radio emission device can control the emissive direction and/or emission intensity. A packet generation unit adjusts packet features other than its contents (e.g., packet length, transmission intensity) based on a switching sequence for specifying the emissive direction and/or emissive intensity, and generate a switching control packet. An emission control unit measures the switching control packet feature other than its contents, and identifies at least one bit as antenna control information. The emission control unit controls the overall directionality of a directional antenna unit based on a bit sequence including at least one bit thus identified. | 10-17-2013 |
20130267488 | PHARMACEUTICAL FORMULATION HAVING NEUROPROTECTIVE ACTIVITY - [Problem] The purpose of the present invention is to provide a neuroprotective agent which is capable of effectively protecting intraocular cells including optic nerves and is effective as a composition for ophthalmic membrane staining in cases where removal of an ophthalmic membrane is carried out. | 10-10-2013 |
20130263379 | MATTRESS - The objective of the present invention is to provide a mattress including a plurality of cells provided on a body pressure working surface of a substrate that supports a human body, and a pressure control means that changes a setting of a height of each cell by adjusting a pressure in a fluid chamber formed within the cell. An elastic cushion layer is provided on a body pressure working surface of the cells, and a constricted portion is formed in a middle in the height of the each cell so that the body pressure working surface of the cell is allowed to tilt following deformation of the cushion layer as a result of the cells' precession-deformation at the constricted portion. | 10-10-2013 |
20130252265 | METHOD FOR TESTING FOR CEREBRAL INFARCTION VIA CARTILAGE ACIDIC PROTEIN 1 - A test method for diagnosing cerebral infarction, a test method for diagnosing the disease type of cerebral infarction, and a test method for predicting prognosis of cerebral infarction in a subject animal, which test methods comprise the step of measuring the amount of cartilage acidic protein 1 in a blood sample collected from the animal. | 09-26-2013 |
20130212721 | REAGENT FOR TUMOR TESTING AND PHARMACEUTICAL COMPOSITION FOR TUMOR PREVENTION - The present invention aims to provide a novel reagent for tumor testing and a novel pharmaceutical composition for tumor prevention. | 08-15-2013 |
20130207081 | ORGANIC SEMICONDUCTOR DEVICE AND ITS PRODUCTION METHOD, AND COMPOUND - An organic semiconductor device which has an organic semiconductor layer formed by crystallizing a compound represented by the following formula (1) from a solution of the compound: | 08-15-2013 |
20130203134 | METHOD FOR PRODUCING L-LACTIC ACID BY LACTIC ACID BACTERIUM UNDER PRESENCE OF PENTOSE AND CELLOOLIGOSACCHARIDES - The present invention thus provides a method for producing L-lactic acid, which comprises the step of culturing a lactic acid bacterium that can produce L-lactic acid in a medium containing any one selected from the group consisting of cellobiose, cellooligosaccharides, xylose, arabinose, and glucose derived from cellulose and/or hemicellulose as a substrate to obtain L-lactic acid. In a preferred embodiment of the present invention, | 08-08-2013 |
20130197371 | DIAGNOSTIC SYSTEM - A diagnostic system comprises a spectral image shooting means that shoots a spectral image within a predetermined wavelength range in a body cavity and obtains spectral image data, an image processing means that obtains the spectral image data and calculates an indicator indicating an area having a high possibility of a diseased portion from the spectral image data, and a monitor on which the indicator is displayed, and wherein the image processing means calculates, as the indicator, a ratio between an accumulated value of intensity values of all spectral images in the predetermined wavelength range and an intensity value of spectral images in a particular wavelength band, for each coordinate in the spectral image. | 08-01-2013 |
20130172356 | COMBINATION OF EGCG OR METHYLATED EGCG AND A PDE INHIBITOR - Disclosed is a medicament characterized by the combination of: epigallocatechin gallate, methylated epigallocatechin gallate, or a pharmacologically permitted salt thereof; and a phosphodiesterase inhibitor. | 07-04-2013 |
20130171705 | NOVEL LACTIC ACID BACTERIUM AND METHOD FOR PRODUCING L-LACTIC ACID USING SAME - L-Lactic acid fermentation using non-edible biomass requires a lactic acid bacterium suitable for fermentation using a mixture comprising oligosaccharides or mixed saccharides produced by enzymatic treatment of cellulose and hemicellulose, so that simultaneous saccharification and fermentation are enabled. Further, it must be taken into consideration that use of pentoses such as xylose derived form non-edible biomass as the raw material provides lactic acid as well as equimolar acetic acid, which halves the molar yield of lactic acid, and high concentration L-lactic acid induces fermentation inhibition, which makes it difficult to produce L-lactic acid at high yield. The present invention provides a novel lactic acid bacterium that can solve these problems. With the lactic acid bacterium of the present invention, L-lactic acid showing a high optical purity of 99.9% or higher can be efficiently produced by using a mixture of glucose and cellobiose as a raw material without substrate inhibition and substantially without generation of by-products. The method of the present invention is applicable to efficient production of L-lactic acid from a non-edible biomass raw material. | 07-04-2013 |
20130171406 | PROCESS FOR PRODUCING FILM CONTAINING ORIENTED NANOTUBES OR NANOPARTICLES, AND THE FILM - A method is disclosed for producing a film containing oriented nanotubes or nanoparticles. The nanotubes typified by CNTs or nanoparticles are oriented utilizing an electric field, and influence of an electrode is suppressed, thereby allowing for production of a large-area film containing nanotubes or nanoparticles including reliably oriented nanotubes or nanoparticles, at a low cost. The method for producing the film containing nanotubes or nanoparticles which are oriented along the plane direction of the film includes: placing a film precursor containing nanotubes or nanoparticles on an interdigitated comb-like electrode through a support, in which the comb-like electrode is arranged on an insulating plate and configured with electrode wires having a circular cross-section; applying an AC voltage to the comb-like electrode in a state with the film precursor present on the comb-like electrode; and converting the film precursor into a film. | 07-04-2013 |
20130137994 | SENSOR UNIT AND BIOSENSOR - A highly miniaturized biosensor and a sensor unit, which can meet a demand for further miniaturization. With this invention, miniaturization is possible, and the number of production steps including those for assembling individual parts can be reduced. Accordingly, mass production will be possible, and cost reduction and high reliability will be achieved. A light emitting unit ( | 05-30-2013 |
20130137782 | METHOD OF PRODUCING COMPOSITION HAVING CONTINUOUS PHASE AND DISPERSE PHASE DISPERSED FINELY IN THE CONTINUOUS PHASE AND APPARATUS FOR PRODUCING THE COMPOSITON - There is provided a method of producing a composition having a continuous phase and a disperse phase dispersed finely with low polydispersity in the continuous phase, with high production efficiency. | 05-30-2013 |
20130113467 | Angle Detection Apparatus - Provided is an angle detection device capable of detecting the angle with high sensitivity by a very simple assembly process without requiring complicated processing. The angle detection device is provided with: a rotor ( | 05-09-2013 |
20130084305 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT - It is an object of the present invention to provide a cosmetic or external skin preparation that has an improved feel in use, e.g., excellent stretching on the skin surface, excellent permeation into the skin, and no stickiness, or crinkles. A cosmetic or an external skin preparation, and a medical instrument, comprising at least one lipid peptide-based gelator that contains a low-molecular lipid peptide of Formula (1): | 04-04-2013 |
20130072752 | FORCEPS SUPPORT DEVICE - A forceps support device | 03-21-2013 |
20130071365 | INDUCED HEPATOCYTES - An object of the present invention is to produce hepatic cells from non-hepatic cells that can be obtained less invasively and at low cost. The gene of HNF3α, HNF3β, or HNF3γ and the gene of HNF4α are transduced into non-hepatic cells. The present invention enables the production of induced hepatocytes from somatic cells that are non-hepatic cells, such as skin cells. The use of the induced hepatocytes obtained by the present invention can establish and develop, as general medical treatment, cell transplantation into the liver, artificial livers, and drug response tests, which are the areas that have not been generalized because of the difficulty of procuring hepatocytes. | 03-21-2013 |
20130043886 | System for Measuring a Peak Frequency of a Signal for Analyzing Condition of a Subject - A system for measuring a peak frequency of a signal applies a Maximum Entropy Method (MEM) to the signal obtained through transmission and reception of an electromagnetic wave to a subject to obtain a frequency of a peak component to be measured, thus permitting to make an appropriate assessment on a state of the subject. A signal analysis unit performs a spectrum estimation utilizing the MEM applied to a signal part of the phase difference signal with a predetermined short analysis duration, from a phase difference signal obtained by an electromagnetic wave transmitting and receiving unit, to obtain a frequency indicative of occurrence frequency of the peak component, and conducts repeatedly the same process, while shifting a position to be analyzed, corresponding to the analysis duration, thus introducing continuously the frequency. It is therefore possible to know a transition with time of the frequency of the peak component. | 02-21-2013 |
20130022310 | Bistable Element - A bistable element ( | 01-24-2013 |
20130021546 | LIQUID-CRYSTAL DISPLAY ELEMENT AND SUBSTRATE USED IN SAME - A substrate used for a liquid crystal display element having two or more substrates arranged oppositely to each other and a liquid crystal material exhibiting a blue phase between the substrates, where a polar component of surface free energy on a substrate surface in contact with the liquid crystal material is less than 5 mJm | 01-24-2013 |
20130012597 | TEMPERATURE-, PH- OR SALT CONCENTRATION-SENSITIVE SEPARATION MATERIAL AND USE THEREOF - The present invention provides a UCST-type thermoresponsive polymer compound which responds to a temperature under physiological conditions and has biofunctionality, and various uses thereof as a thermoresponsive material. Specifically, the invention provides a thermoresponsive material containing, as an active ingredient, a polymer compound represented by Formula (I) below or an addition salt thereof, the thermoresponsive material having an upper critical solution temperature in the range of 5 to 50° C. in an aqueous solution with a salt concentration of at least 1 mM and a pH in the range of 3 to 10.5: | 01-10-2013 |
20120320781 | COMMUNICATION SYSTEM, A SLAVE NODE, A ROUTE MAKING METHOD AND A PROGRAM - Provided are a communication system and the like capable of making a stable relay route even when a propagation channel is fluctuated by the fluctuation of RSSI. For making a tree-type communication route whose root is a core node, each slave node, after the reception of the latest reset routing packet from a node, judges if the transmission source node should be the parent of the tree-type structure based on the sequential average of the reception power of n routing packets received from the same transmission source node. As the reception power is log-normally distributed in general, an asymptotically stable relay route can be obtained, especially by using the sequential average. | 12-20-2012 |
20120315701 | PEPTIDE INHIBITING DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS OR HEMATOPOIETIC PRECURSOR CELLS AND USE OF SAME - The present invention provides a novel peptide that can be effectively used to produce or grow tissue-specific stem cells or tissue-specific progenitor cells in vitro. The peptide of the invention is a peptide having an amino acid sequence consisting of the amino acid residues set forth in SEQ ID NO:1, or an analog thereof. A feature of the peptide of the invention is having at least one of the following effects: (1) an effect of inhibiting differentiation of hematopoietic stem cells or hematopoietic progenitor cells into myeloid cells, (2) an effect of promoting amplification of mesenchymal stem cells, and (3) an effect of inducing hematopoietic stem cells from pluripotent stem cells. | 12-13-2012 |
20120315684 | Plasma Oxidation-Reduction Method, Method for Promoting Plant/Animal Growth Using the Same, and Plasma-Generating Device for Use in Method for Promoting Plant/Animal Growth - Provided is a plasma oxidation-reduction method with which it is possible to control the structure of amino acids and proteins with high and stable reproducibility, by using plasma in order to control the amino acids and proteins that make up a living body, particularly by using plasma in order to oxidize or reduce amino acids and proteins. Also provided are a method for promoting plant/animal growth using the plasma oxidation-reduction method, and a plasma-generating device for use in the method for promoting plant/animal growth. Amino acids or proteins are oxidized or reduced in the plasma oxidation-reduction method by using an active oxygen species or active hydrogen in the plasma. Preferably, the active oxygen species comprises any one of singlet oxygen atoms, excited oxygen molecules, or hydroxyl radicals, and the active hydrogen comprises excited hydrogen atoms. | 12-13-2012 |
20120276644 | Method for Detecting Endogenous Biomolecules - Provided is a method for the real-time visualization of an endogenous biomolecule to clarify the mechanisms of various diseases and enable diagnosis and treatment of these diseases. Specifically provided is a novel method for visualizing an endogenous biomolecule by using a magnetic resonance method (including Overhauser MRI and the electron spin resonance method). The aforesaid visualization method, whereby an endogenous biomolecule is visualized on a real-time basis, comprises: a step for treating a living organism to be examined by a magnetic resonance method and thus acquiring data of the endogenous biomolecule; a step for processing the data of the endogenous biomolecule thus obtained to give imaging data; and a step for displaying the imaging data thus obtained. | 11-01-2012 |
20120247557 | ORGANIC SOLAR CELL - This invention has an objective of producing the organic solar cell having the long life. The organic solar cell of this invention comprises a first electrode collecting holes, a second electrode collecting electrons, mixing layer interposed between the first electrode and the second electrode and having an electron donating semiconductor and the electron accepting semiconductor, and a first electron transport layer and a second electron transport layer interposed between the mixing layer and the second electrode. With this invention, the adhesiveness in the boundary between the mixing layer and the second electrode is improved. Consequently, it is possible to prevent the mixing layer from accumulating the electrical charge generated by absorbing the light. Therefore, the electrical charge is efficiently moved to the second electrode and the long life is achieved. | 10-04-2012 |
20120217869 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE - A delayed fluorescence material containing a mixture of an acceptor compound and a donor compound that satisfies the following formulae (1) to (4): | 08-30-2012 |
20120207794 | WATER-SOLUBLE DRUG CARRIER AND PROCESS FOR PRODUCING THE SAME - An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver water-soluble drugs such as genes and proteins in a wide range of applications, including delivery of water-soluble drugs that do not have high anionic properties, and also can be used as a non-viral gene vector. The invention also provides a process for production of such drug delivery carriers. The drug delivery carrier of the present invention includes a water-soluble drug double-coated with two types of inner and outer surfactants 1 and 2. | 08-16-2012 |
20120189617 | ANTI-TIM-3 ANTIBODY - The present invention provides an anti-human TIM-3 antibody which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure thereof and exhibits higher effector activity such as an antibody-dependent cellular cytotoxicity (ADCC activity) for diseases relating to a human TIM-3 expressing cell. The present invention provides a monoclonal antibody or antibody fragment thereof which binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure and exhibits ADCC activity; a hybridoma which produces the antibody; a DNA encoding the antibody; a vector comprising the DNA; a transformant which is obtainable by introducing the vector; a method for producing the antibody or the antibody fragment thereof which comprises using the hybridoma or the transformant; a therapeutic agent and a diagnostic agent comprising the antibody or the antibody fragment thereof as an active ingredient. In addition, the present invention provides an anti-human TIM-3 antibody having high ADCC activity by screening an anti-human TIM-3 antibody which competes with the monoclonal antibody or the antibody fragment thereof. | 07-26-2012 |
20120186349 | METHOD AND SYSTEM FOR NON-DESTRUCTIVE TESTING - Provided herein is a non-destructive testing method capable of diagnosing a condition of an object to be tested using a single-pulse ultrasonic wave signal. An attenuation waveform of the single-pulse ultrasonic wave signal received by a receiving section | 07-26-2012 |
20120172344 | INSULIN-PRODUCING CELL INDUCER, GLUCOSE INTAKE ENHANCER, AND THERAPEUTIC AGENT FOR DIABETES OR DIABETES COMPLICATIONS - Provided is an insulin-producing cell inducer, an enhancer for glucose intake of muscles, and a therapeutic agent for diabetes or diabetes complications, wherein an active ingredient of those provided is an estrogenic compound such as estrogen and estradiol. With the present invention, functions of insulin-producing cells can be recovered since the insulin-producing cells are induced in pancreatic ducts, and blood glucose level can be immediately lowered since glucose in the blood can be effectively taken up by muscles; therefore, diabetes and diabetes complications can be prevented or treated. | 07-05-2012 |
20120165886 | ELECTRICAL STIMULATION DEVICE FOR TREATING CARDIOVASCULAR DISEASE AND METHOD FOR TREATING CARDIOVASCULAR DISEASE - The object of the invention is to provide a new treatment method and treatment device that together with being able to improve a drop in cardiac contractility when treating cardiovascular disease such as acute myocardial infarction and suppress the occurrence of arrhythmia, is able to reduce the infarct size. Provided is an electrical stimulation device for treating cardiovascular disease having at least one electrode that is placed on a nerve site in the body of an animal, and an electrical stimulation application unit that applies electrical stimulation by the electrode to the vagus nerve in the neck region of the animal; and a method for treating cardiovascular disease in an animal having a step of placing an electrode in contact with the vagus nerve in the neck region of an animal, and a step of applying electrical stimulation to the animal. | 06-28-2012 |
20120156710 | METHOD FOR QUANTIFYING PROTEIN - The present invention provides a method that is useful for measuring the absolute amount of a target protein contained in a protein mixture, such as a biological sample. The method of the present invention includes the steps of:
| 06-21-2012 |
20120108680 | LONG-CHAIN GLYCYL POLYOL TYPE GELATOR AND GEL - A gelator made of an aliphatic oxyglycyl polyol that is capable of forming a gel by a small amount of addition in a pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility and biodegradability. A gelator including an aliphatic oxyglycyl polyol of Formula (1) wherein R is a C | 05-03-2012 |
20120107524 | THIN-FILM MANUFACTURING METHOD AND APPARATUS - A thin-film manufacturing method includes the steps of: generating a plasma from source gas; extracting ions from the plasma; and depositing a thin film on one side or both sides of a substrate to be deposited with the ions. The method is performed in an apparatus including: a plasma chamber generating the plasma; a film deposition chamber accommodating the substrate to be deposited; an ion transfer path for transferring the ions from the plasma chamber to the film deposition chamber; a branch pipe branching from the ion transfer path; and an exhaust system connected to the branch pipe. The thin film is formed while the source gas except the ions is exhausted from the branch pipe. | 05-03-2012 |
20120100550 | METHOD FOR DETERMINING FATTY ACID SYNTHESIS PATHWAY OF MICROORGANISM, AND PCR PRIMER SET FOR USE IN THE METHOD - Disclosed is a method for determining the fatty acid synthesis pathway of a microorganism. Specifically disclosed is a method for determining the fatty acid synthesis pathway of a microorganism, which is characterized by producing degenerate primers for a fatty acid synthesis-related enzyme gene and determining the presence or absence of the fatty acid synthesis-related gene in the genome gene extracted from the microorganism using the degenerate primers. The sequences for degenerate primers for C20-elongase gene, which is a fatty acid synthesis-related enzyme gene, are ATHGARTWYTKBRTITTYGTICA (SEQ ID NO:1) and TARTRISWRTACATIADIAMRTG (SEQ ID NO:2), and the sequences for degenerate primers for ?4-desaturase gene are GGNCAYCAYCMITAYACNAA (SEQ ID NO:3) and TCDATYTGRTGIBWIARNCC (SEQ ID NO:4). The microorganism is one belonging to the class Labyrinthulea. Also specifically disclosed is a PCR primer set for use in the determination method. The method is useful as a method for screening a microorganism capable of synthesizing a fatty acid. | 04-26-2012 |
20120094914 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR RHEUMATOID ARTHRITIS OR RHEUMATOID ARTHRITIS-RELATED DISEASES - Disclosed is a prophylactic or therapeutic agent for rheumatoid arthritis or diseases caused by rheumatoid arthritis (rheumatoid arthritis-related diseases), which comprises HLA-G or a dimer thereof as an active ingredient. As the HLA-G, the following protein (a) or (b) are suitably used.
| 04-19-2012 |
20120086216 | FLUID MACHINE, WIND TURBINE, AND METHOD FOR INCREASING VELOCITY OF INTERNAL FLOW OF FLUID MACHINE, UTILIZING UNSTEADY FLOW - A fluid machine, a wind turbine, and a method for increasing velocity of an internal flow is provided. A basic shape of the casing has a cycloid curve having a convex portion at a throat section between the front and rear edges. The throat section and a vortex generating face disposed downstream of the throat section to generate the negative pressure region are formed on an inner circumferential face of the casing. A first outflow gradient is formed on an outer circumferential face of the casing and at the rear edge. A second outflow gradient is formed on a boundary of a throat-side adjacent face adjacent to the vortex generating portion to separate the internal flow. The negative pressure region of high vorticity is generated behind the vortex generating face by virtue of the non-streamline shaped casing to increase the velocity of the internal flow. | 04-12-2012 |
20120082922 | COMPOSITE ELECTRODE MATERIAL AND METHOD OF PRODUCING THE SAME, NEGATIVE ELECTRODE FOR METAL-AIR BATTERY, AND METAL-AIR BATTERY - The present invention relates to a composite electrode material having a carbon base material and iron oxide particles mainly containing Fe | 04-05-2012 |
20120070381 | OPHTHALMOLOGIC COMPOSITION HAVING GELATION ABILITY - Disclosed is a material for use in ophthalmologic organ replacement, which is transparent, has controllable physical properties, and can have physical properties suitable for use as an ophthalmic tissue when the hardness of a gel produced from the material or the fluidability of a sol produced from the material at a specific temperature or lower is varied. Specifically disclosed is an ophthalmologic composition capable of forming a gel, which comprises a polyethylene glycol that is represented by formula 1 and has one end modified with a long-chain alkyl group, a polyethylene glycol that is represented by formula 2 and has both ends modified with a long-chain alkyl group, and a solvent. | 03-22-2012 |
20120024077 | INCLUSION RATING METHOD - An inclusion rating method includes carrying out a tensile test on a test specimen, which is made of a metallic material and charged with a hydrogen, to cause a fracture originating from a nonmetallic inclusion affected by the hydrogen in the test specimen, identifying a type of the nonmetallic inclusion, measuring a size of the nonmetallic inclusion, and evaluating a cleanliness of the metallic material by obtaining a distribution function of the size of the nonmetallic inclusion. | 02-02-2012 |
20110295383 | BONE SUBSTITUTE MATERIAL FOR MEDICAL USE AND METHOD OF PRODUCING THE SAME - There is disclosed a bone substitute material for medical use which satisfies all the requirements of (1) no histotoxicity, (2) osteoconductivity, (3) bone replacement capability, and (4) mechanical strength necessary for a bone reconstruction operation. The bone substitute material for medical use is predominantly composed of carbonate apatite and produced through the formation of carbonate apatite by contacting a block of calcium compound with a phosphate-containing solution, wherein the calcium compound block contains substantially no powders, and at least one of said calcium compound block and said phosphate solution contains a carbonate group, without any sintering. The block of calcium compound is preferably one prepared using an artificially synthesized calcium compound, most preferably a foamed calcium compound. | 12-01-2011 |
20110263861 | QUINOLINE COMPOUND - Provided is a solid luminescent quinoline compound capable of emitting light in a crystalline state, capable of changing the luminescent color not requiring modification of molecular configuration and capable of emitting light in response to external pressure such as heat, physical pressure, etc. The quinoline compound is represented by the following general formula (1): | 10-27-2011 |
20110217707 | EVALUATION/SCREENING METHOD FOR DISEASES ASSOCIATED WITH D-AMINO ACID UTILIZING DA01-/-MOUSE - Disclosed is an evaluation method which can rapidly discriminate a Dao | 09-08-2011 |
20110202107 | BLOOD PRESSURE STABILIZATION SYSTEM USING TRANSDERMAL STIMULATION - The present invention relates to an electric stimulation apparatus for treating hypotension of patients with spinal cord injury and a method for treating hypotension. An electric stimulation apparatus of the present invention comprises: a blood pressure measuring means for continuously measuring a blood pressure of a subject; an electric current application means for intermittently applying an electric current to skin of the subject; and a control means for controlling the electric current application means so as to maintain the blood pressure at a predetermined target blood pressure value by activating the electric current application means when the subject blood pressure is equal to or less than the target blood pressure value. | 08-18-2011 |
20110193734 | SIGNAL CONVERTER, PARAMETER DECIDING DEVICE, PARAMETER DECIDING METHOD, PROGRAM, AND RECORDING MEDIUM - A signal converter and the like, which can more accurately and stably realize signal conversion between an analog signal and a digital signal are proposed. In a β-encoder, when a logic value generated by at least a quantizer | 08-11-2011 |
20110189671 | NUCLEOSIDE TRIPHOSPHATE DERIVATIVE, NUCLEIC ACID PROBE, MULTILABELED NUCLEIC ACID PROBE, METHOD FOR PRODUCTION OF MULTILABELED NUCLEIC ACID PROBE, AND METHOD FOR DETECTION OF TARGET NUCLEIC ACID - A novel nucleoside triphosphate derivative, a nucleic acid probe, and a multilabeled nucleic acid probe that can detect a target nucleic acid conveniently and with high sensitivity, as well as a method for producing the multilabeled nucleic acid probe, and a method for detecting a target nucleic acid using the multilabeled nucleic acid probe or the nucleic acid probe. A target nucleic acid can be detected conveniently and with high sensitivity by using a transglutaminase (TGase), and by using a multilabeled nucleic acid probe in which a plurality of labeling portions have been introduced in advance by covalent binding, or by introducing a plurality of labeling portions by covalent binding into a nucleic acid probe that has been hybridized with the target nucleic acid. | 08-04-2011 |
20110184147 | ENZYME SUBSTRATE FOR LABELING OF PROTEIN - The present invention provides a substrate of TGase represented by (fluorescent group)-(linker)-(a portion containing a Gln residue capable of recognition by transglutaminase (TGase))-R, wherein the fluorescent group is fluorescein isothiocyanate (FITC), Texas Red (TE) or dansyl (Dns) or a group derived therefrom; the linker is a group represented by —NH—(CH | 07-28-2011 |
20110183058 | Pasteurizing Method and Pasteurizing Apparatus - In order to provide a pasteurizing method that provides high pasteurizing effect in pasteurization of an object to be treated and that hardly causes denaturation of the treated object, the method includes a dropping step of dropping the object in a steam zone and a contacting step of causing the dropping object to come into contact with the steam. | 07-28-2011 |
20110124916 | THERMAL RESPONSIVE MOLECULE - Provided is a thermal responsive molecule favorable as a thermal responsive low-molecular hydrogelling agent or the like that gels in response to heat. The thermal responsive molecule is characterized in that an amphiphilic side chain obtained by bonding a hydrophilic side chain such as triethylene glycol and a hydrophobic group such as an octyl group is introduced into a C | 05-26-2011 |
20110117588 | METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS - The present invention provides a method of predicting drug-induced phospholipidosis, comprising a step of contacting a mammalian cell with a test compound, a step of measuring extracellular and/or intracellular lysosomal enzyme level or activity, or measuring intracellular LC3 level, and a step of selecting a test compound that has enhanced extracellular secretion of the enzyme or increased the protein level as a compound capable of inducing drug-induced phospholipidosis. | 05-19-2011 |
20110111051 | PROPHYLACTIC OR ALLEVIATING AGENT FOR PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENT - There is provided a medicinal agent that is effective and highly safe for the prevention or alleviation of a peripheral nerve disorder that develops as a side effect occurring after the administration of an anti-cancer agent. The present invention relates to a novel medical use of an extract from inflamed tissues inoculated with vaccinia virus, and to a prophylactic or alleviating agent for a peripheral nerve disorder that contains the extract as an active ingredient. The agent containing the extract as an active ingredient is used for a prophylactic or alleviating agent for a peripheral nerve disorder induced by an anti-cancer agent and is a highly safe and remarkably highly useful medicinal agent with few side effects. | 05-12-2011 |
20110110233 | NETWORK SYSTEM, NODE, PACKET FORWARDING METHOD, PROGRAM, AND RECORDING MEDIUM - There is proposed a network system and the like achieving a packet relay transmission with high relay transmission efficiency according to Intermittent Periodic Transmit method (IPT). In order to achieve Intermittent Periodic Transmit in a mesh cluster, a communication control unit of a core node selects one of a plurality of communication units according to downlink priority and causes the selected communication unit to transmit a packet with a periodic interval. In order to transmit a packet from the core node to another slave node, a communication control unit of a slave node selects one of the communication units according to downlink priority, and in order to transmit a packet from a slave node to the core node, the communication control unit of the slave node selects one of the communication units according to uplink priority. Then, the communication control unit causes the selected communication unit to transmit the packet. | 05-12-2011 |
20110090835 | NETWORK SYSTEM, NODE,PACKET FORWARDING METHOD, PROGRAM, AND RECORDING MEDIUM - There are proposed: a network system capable of realizing packet forwarding higher in packet forwarding efficiency than in conventional Intermittent Periodic Transmit (IPT) using omni-directional antennas; and the like. Directional antennas are applied to the IPT, and each of slave nodes waits for reception of downlink packets by a directional antenna for receiving the downlink packets in a reception waiting state therefor. Moreover, the downlink packets are treated like polling control signals, and uplink packets are transmitted at a reception time of the downlink packets, whereby a hidden node problem and a carrier sensing problem can be avoided. Furthermore, in accordance with routing protocol in which each of nodes changes directivity randomly by a route formation process, it becomes possible to form a more suitable route. | 04-21-2011 |
20110042952 | FLUID MACHINE, WIND TURBINE, AND METHOD FOR INCREASING VELOCITY OF INTERNAL FLOW OF FLUID MACHINE, UTILIZING UNSTEADY FLOW - A fluid machine includes a non-streamline casing capable of forming a stable vortex street on a downstream side by internal and external flows, and an impeller disposed inside the casing. The casing has a vortex generator configured to form the vortex street on the downstream side. The vortex generator is provided with a phase control structure which regulates a phase of a vortex formation that fluctuates along a circumferential direction in a plane including a rear face of the casing and which clarifies a cell structure to be formed along the circumferential direction of the casing to fix, on a surface of the casing, respective positions of cells into a plurality of segmented regions arranged in the circumferential direction. The velocity of the internal flow is increased by the phase control structure. | 02-24-2011 |
20110015486 | ENDOSCOPE SYSTEM AND ENDOSCOPIC OPERATION TRAINING SYSTEM - An endoscope system or an endoscopic operation training system includes: projectors which project video light indicating a video taken by an endoscope device that allows at least a part thereof to be inserted into patient's body cavity; and a dome type screen having a shape of a projection surface that directs a concave surface toward an operator and assistants, in which the video light is projected onto the projection surface. In a case where an axis that passes through a center of an opening surface thereof and is perpendicular to the opening surface is defined as a first axis, a point where the first axis and the projection surface intersect each other is defined as a projection surface center, and an axis that connects the projection surface center and an edge portion of the projection surface to each other is defined as a second axis, and a tangential line of the edge portion of the projection surface is defined as a third axis, then an angle made by the first axis and the third axis is an angle at which it is possible to observe a whole of the video from the first viewpoint position, and an angle made by the first axis and the second axis is an axis at which it is possible to observe the projection surface center from the second viewpoint position. | 01-20-2011 |
20110003321 | Monitoring of Intercellular Mitochondorial Polarization - An object is a method of detecting changes in mitochondrial polarized state in a living cell. | 01-06-2011 |
20100331373 | DRUG-CONTAINING NANOPARTICLES - The present invention relates to nanoparticles containing pioglitazone or a salt thereof and a biocompatible polymer, a pharmaceutical preparation containing the nanoparticles for the prophylaxis or treatment of arteriosclerotic diseases, and a stent carrying the nanoparticles. Using the nanoparticles of the present invention, rupture of arteriosclerotic plaque can be suppressed, and they are useful for the prophylaxis or treatment of arteriosclerotic diseases. | 12-30-2010 |
20100321138 | SEPARATE TYPE MAGNETIC SHIELD APPARATUS - It is an object of the present invention to provide a separate type magnetic shield apparatus which has high access performance to a magnetically shielded space, in which magnetic shielding is very effectively achieved. In the separate type magnetic shield apparatus, first and second conductors | 12-23-2010 |
20100308313 | Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same - [Object] To provide a wide band-gap material capable of forming a stable amorphous thin film and an organic electroluminescent device using such a compound and having a high light emission efficiency. | 12-09-2010 |
20100300987 | FILTRATION APPARATUS AND FILTRATION METHOD - The present invention has an object to provide a filtration apparatus and a filtration method which can treat a large quantity of flow in a short time and can sterilize raw water to a high level using only a physical treatment. The filtration apparatus and the filtration method according to the present invention includes a spring filter | 12-02-2010 |
20100216977 | THERAPEUTIC AGENT FOR INTERSTITIAL PULMONARY DISEASE COMPRISING ANTI-HMGB-1 ANTIBODY - An objective of the present invention is to provide effective methods for treating interstitial pulmonary diseases including interstitial pneumonia such as IPF. The present invention suggests that antibodies against HMGB-1 are effective for treating pulmonary fibrosis. Thus, the present invention provides preparations which comprise an anti-HMGB-1 antibody for treating interstitial pulmonary diseases. | 08-26-2010 |
20100207796 | CONVERTER, CONVERSION METHOD, PROGRAM, AND RECORDING MEDIUM - Provided is a highly accurate converter and the like that makes up for the instability of circuit elements, by focusing on a relationship between the Markov chain and β conversion. A converter | 08-19-2010 |
20100112446 | ACTIVE ELECTRODE MATERIAL, MANUFACTURING METHOD OF SAME, AND LITHIUM-ION BATTERY USING THAT ACTIVE ELECTRODE MATERIAL - Electrode active material is provided which is mainly an amorphous iron-phosphate complex represented by Li | 05-06-2010 |
20100086615 | AGENT FOR TREATMENT OF PULMONARY DISEASE - To provide a pulmonary disease therapeutic drug exhibiting high efficacy and reduced side effects. | 04-08-2010 |
20100067365 | TRANSMISSION SYSTEM, TRANSMISSION METHOD, TRANSMITTER, RECEIVER, DECODING METHOD, AND DECODER - A transmission system capable of obtaining an effect of orthogonality among time block codes and an effect of path diversity on a distorted channel is provided. In the transmission system including: a transmitter device transmitting an information signal S[n] multiplied by a code, the code being a time block code constituted by a plurality of time series symbols, the transmitter device multiplying the information signal by a plurality of the time block codes, respectively, multiplexing multiplication results on a time axis and transmitting multiplexed signals; and a receiver device including a reception filter, if an impulse response matrix of a channel is a matrix H, a characteristic of the reception filter is set to be represented by a complex conjugate transpose matrix H | 03-18-2010 |
20100063048 | Remedy for angiospasm accompanying subarachnoid hemorrhage containing thrombin receptor antagonist as the active ingredient - A therapeutic agent for subarachnoid hemorrhage or a drug for improving prognosis of subarachnoid hemorrhage, comprising a compound having a PAR1 inhibitory effect, its pharmaceutically acceptable salt or a hydrate thereof | 03-11-2010 |
20100040323 | SUPER-LUMINESCENT LIGHT EMITTING DIODE - To provide a super luminescent light emitting diode comprising an optical waveguide structure which supplies particularly-high optical output. The super-luminescent light emitting diode includes: a first optical waveguide, of which one end is optically connected to one end of a multimode interference optical waveguide, and of which the other end forms a first light emitting edge; and a second optical waveguide, of which one end is optically connected to the other end of the multimode interference optical waveguide, and of which the other end forms a second light emitting edge. Each of the first and second optical waveguides has a width smaller than the width of the multimode interference optical waveguide. | 02-18-2010 |
20100035155 | CATHODE ACTIVE MATERIAL FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND MANUFACTURING METHOD OF THE SAME - In a non-aqueous electrolyte secondary battery, in order to adjust a cathode active material in which guest cation such as Na and Li is included, alkaline metal fluoride which is expressed by a general formula AF and transition metal fluoride which is expressed by a formula M′ F | 02-11-2010 |
20090323010 | Liquid Crystal Composition and Liquid Crystal Element - The invention provides a liquid crystal composition having an optically isotropic liquid crystal phase used in an element driven in a state of an optically isotropic liquid crystal phase, which comprises a compound I having the clearing point T | 12-31-2009 |
20090305385 | Novel Cultured Silkworm Cells Capable of Highly Efficient Baculovirus Production and Protein Production - Known cell lines derived from silkworm exhibit low propagation efficiency of BmNPV. Accordingly, systems using known culture cell lines derived from silkworms take a long time to establish recombinant viruses, and are not suitable for preparation of virus solutions with high titers. The present invention provides a cell line Bme21 (FERM P-20852) that is derived from a silkworm embryo and is highly susceptible to BmNPV or its variant having the same biological characteristics. The present invention also provides a method of producing a recombinant virus, a method of producing a recombinant protein, a method of increasing efficiency of recombinant virus production, and a method of increasing efficiency of recombinant protein production, using the cell line Bme21 or its variant. | 12-10-2009 |
20090296638 | Wireless Communication Apparatus, Wireless Communication Method and Wireless Communication Program - In accordance with the present application, it is possible to determine whether or not it is appropriate to apply SDMA by estimating the fading speed of mobile stations. A wireless communication apparatus of the present application includes: a fading speed estimation portion ( | 12-03-2009 |
20090250333 | Method of Solubilizing Carbon Nanomaterial - [Problems] The present invention is to provide a method of solubilizing a carbon nanomaterial, in which a carbon nanomaterial can be dissolved in a hydrophilic solvent easily and uniformly without structural deterioration of the carbon nanomaterial, the dispersibility can be maintained for a prolonged period of time, the solubilizing treatment can be performed at low cost, and the treatment can be easily controlled. | 10-08-2009 |
20090131271 | METHOD FOR DELIVERING NUCLEIC ACID AND DEVICE FOR DELIVERING NUCLEIC ACID - In a method for delivering a nucleic acid of the invention, a nucleic acid is introduced into a cell by pressing the nucleic acid supported on a surface of a solid substrate against the cell. According to the method, the nucleic acid can be delivered into the cell simply at a low cost without placing a heavy burden on the cell at a high nucleic acid delivery efficiency. By allowing the surface of the solid substrate to support the nucleic acid in the form of a complex with a polyamine or a cationic lipid and pressing it against the cell, the introduction efficiency into the cell can be further improved. In the invention, by using a nucleic acid useful for gene therapy as the nucleic acid, a high-efficiency device for gene therapy can be obtained. | 05-21-2009 |
20090114374 | HEAT REMOVAL METHOD AND HEAT REMOVAL APPARATUS - A heat removal apparatus able to remove heat with a high heat flux from a large area is provided. A heat removal apparatus | 05-07-2009 |
20090103852 | ANALYZING ELEMENT AND ANALYZING APPARATUS USING SAME - An analyzing element ( | 04-23-2009 |
20090099646 | BIOFILM FORMATION INHIBITOR AND TREATMENT DEVICE THEREOF - A treatment device such as a biliary stent, capable of effectively and continuously inhibiting biofilm formation, and a biofilm formation inhibitor suitable for coating on the treatment device by killing all bacteria including | 04-16-2009 |
20090097021 | Substrate and Substrate Assembly for Use in Raman Spectroscopic Analysis - To provide a substrate and a substrate assembly for Raman spectroscopic analysis that are capable of analyzing even a substance of a low concentration with high sensitivity. | 04-16-2009 |
20090091251 | ORGANIC EL DEVICE - An organic EL device including a substrate, a positive electrode layer, a first organic layer containing a first organic light-emitting material, a negative electrode layer made of metal, and a second organic layer containing a second organic light-emitting material capable of emitting light by absorbing at least a part of light emitted from the first organic light-emitting material, in this order is provided. The negative electrode layer preferably includes a layer made of Ag. | 04-09-2009 |
20090090933 | METHOD OF PRODUCING STRAINED Si-SOI SUBSTRATE AND STRAINED Si-SOI SUBSTRATE PRODUCED BY THE SAME - A strained Si-SOI substrate, and a method for producing the same are provided, wherein the method includes the steps of growing a SiGe mixed crystal layer | 04-09-2009 |
20080291453 | Surface Plasmon Resonance Phenomenon Measuring Equipment - The present invention discloses surface plasmon resonance phenomenon measuring equipment comprising:
| 11-27-2008 |
20080280071 | POLYMER/LIQUID CRYSTAL COMPOSITE AND LIQUID CRYSTAL ELEMENT - The invention is generally related to a polymer/liquid crystal composite, which includes a liquid crystal material which exhibits an optically isotropic liquid crystal phase in the temperature range of approximately 5° C. or more in the elevated temperature process but does not exhibit a nematic phase; and a polymer, and which is used for an element driven in a state of the optically isotropic liquid crystal phase. | 11-13-2008 |
20080262080 | Allergy Suppressive Agent - The present invention provides a novel agent/composition using a bioregulatory function of a food ingredient. | 10-23-2008 |